In Other News

• Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

• Handheld Device Improves Targeted Cell Collection for Early Ovarian Cancer Assessment

• Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

• Genomic Breast Cancer Study Adds Real-World Evidence Across Diverse Patient Populations

• FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

• Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

• Mayo Clinic Laboratories and Pathology Asia Expand Genomic Testing Across Asia-Pacific

• Computational Filters Enhance Metagenomic Detection of Meningitis and Encephalitis

• Computational Filters Enhance Metagenomic Detection of Meningitis and Encephalitis

• Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

• Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

• New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

• New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

• CSF Liquid Biopsy Could Help Distinguish Cancer from Autoimmune Brain Inflammation

• Simple Test Could Reduce the Need for Invasive Uterine Cancer Checks

• Multi-Cancer Early Detection Test Wins FDA Panel Backing for Approval

• Multi-Cancer Early Detection Test Wins FDA Panel Backing for Approval

• Mpox Analysis Reveals Substantial Suspected False Positives Associated with Contamination

• Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

• New Donor Genetic Marker May Help Predict Stem Cell Transplant Success

• Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

• Study Finds Frequent Overlap in Antibodies to Lyme and Other Tick-Borne Pathogens

• First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage